Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.
MER Indicator |
MER description |
Target Fiscal Year |
Target |
BS_COLL |
Number of whole blood collections each year by the NBTS ne2rk |
2015 |
10,260 |
HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female |
2015 |
25 |
HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male |
2015 |
22 |
HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female |
2015 |
9,262 |
HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male |
2015 |
1,140 |
HTS_TST |
Number of individuals who received T&C services for HIV and received their test results during the past 12 months |
2015 |
10,449 |
HTS_TST |
Sum of Aggregated Age/Sex <15 |
2015 |
47 |
HTS_TST |
Sum of Aggregated Age/Sex 15+ |
2015 |
10,402 |
HTS_TST |
Sum of Aggregated Age/Sex disaggregates |
2015 |
10,449 |
LAB_ACC |
Number of PEPFAR-supported testing facilities (laboratories) that are recognized by national, regional, or international standards for accreditation or have achieved a minimal acceptable level towards attainment of such accreditation |
2015 |
1 |
LAB_CAP |
Number of PEPFAR-supported testing facilities with capacity to perform clinical laboratory tests |
2015 |
1 |
PMTCT_ARV |
Life-long ART (including Option B+) |
2015 |
8 |
PMTCT_ARV |
Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) |
2015 |
114 |
PMTCT_ARV |
Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery |
2015 |
8 |
PMTCT_ARV |
Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy |
2015 |
1 |
PMTCT_ARV |
Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy |
2015 |
7 |
PMTCT_ARV |
Sum of New and Current disaggregates |
2015 |
8 |
PMTCT_ARV |
Sum of Regimen Type disaggregates |
2015 |
8 |
PMTCT_EID |
Number of HIV- positive pregnant women identified during the reporting period (include known HIV-positive women at entry into PMTCT) |
2015 |
114 |
PMTCT_EID |
Number of infants who had a virologic HIV test within 12 months of birth during the reporting period |
2015 |
60 |
PMTCT_STAT |
Number of new ANC and L&D clients |
2015 |
14,000 |
PMTCT_STAT |
Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) |
2015 |
4,484 |
SITE_SUPP |
By program area/support type: Care and Support Direct Service Delivery (DSD) |
2015 |
1 |
SITE_SUPP |
By program area/support type: Food and Nutrition Direct Service Delivery (DSD) |
2015 |
1 |
SITE_SUPP |
By program area/support type: HTC Direct Service Delivery (DSD) |
2015 |
65 |
SITE_SUPP |
By program area/support type: PHDP/Family Planning & Integration Direct Service Delivery (DSD) |
2015 |
65 |
SITE_SUPP |
By program area/support type: PMTCT Direct Service Delivery (DSD) |
2015 |
64 |
SITE_SUPP |
By program area/support type: TB/HIV Direct Service Delivery (DSD) |
2015 |
1 |
SITE_SUPP |
By program area/support type: Treatment Direct Service Delivery (DSD) |
2015 |
1 |
SITE_SUPP |
Number of unique sites supported by PEPFAR |
2015 |
66 |
TX_CURR |
Aggregated Age/Sex: <15 Female |
2015 |
38 |
TX_CURR |
Aggregated Age/Sex: <15 Male |
2015 |
34 |
TX_CURR |
Aggregated Age/Sex: 15+ Female |
2015 |
768 |
TX_CURR |
Aggregated Age/Sex: 15+ Male |
2015 |
862 |
TX_CURR |
Number of adults and children receiving antiretroviral therapy (ART) |
2015 |
1,702 |
TX_CURR |
Sum of Aggregated Age/Sex <15 |
2015 |
72 |
TX_CURR |
Sum of Aggregated Age/Sex 15+ |
2015 |
1,630 |
TX_CURR |
Sum of Aggregated Age/Sex disaggregates |
2015 |
1,702 |
TX_NEW |
Aggregated Grouping by Age/Sex: <15 Female |
2015 |
4 |
TX_NEW |
Aggregated Grouping by Age/Sex: <15 Male |
2015 |
5 |
TX_NEW |
Aggregated Grouping by Age/Sex: 15+ Female |
2015 |
75 |
TX_NEW |
Aggregated Grouping by Age/Sex: 15+ Male |
2015 |
92 |
TX_NEW |
Number of adults and children newly enrolled on antiretroviral therapy (ART) |
2015 |
176 |
TX_NEW |
Pregnancy status |
2015 |
7 |
TX_NEW |
Sum of Aggregated Age/Sex disaggregates |
2015 |
176 |
TX_RET |
Number of adults and children who are still alive and on treatment at 12 months after initiating ART |
2015 |
137 |
TX_RET |
Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up |
2015 |
160 |